Catalyst Pharm Inc (CPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 29,317 | 29,605 | 29,137 | 30,122 | 30,897 |
| Cost of Goods | 3,879 | 4,140 | 4,151 | 4,398 | 4,388 |
| Gross Profit | 25,438 | 25,465 | 24,986 | 25,724 | 26,510 |
| Operating Expenses | 14,613 | 15,323 | 14,437 | 18,116 | 13,052 |
| Operating Income | 11,704 | 10,282 | 10,700 | 8,006 | 13,845 |
| Other Income | 33 | 111 | 336 | 399 | 393 |
| Pre-tax Income | 11,737 | 10,393 | 11,036 | 8,405 | 14,239 |
| Income Tax | -31,603 | 613 | 610 | 476 | 608 |
| Net Income Continuous | 43,340 | 9,780 | 10,426 | 7,929 | 13,630 |
| Net Income | $43,340 | $9,780 | $10,426 | $7,929 | $13,630 |
| EPS Basic Total Ops | 0.42 | 0.09 | 0.10 | 0.08 | 0.13 |
| EPS Basic Continuous Ops | 0.42 | 0.09 | 0.10 | 0.08 | 0.13 |
| EPS Diluted Total Ops | 0.41 | 0.09 | 0.10 | 0.08 | 0.13 |
| EPS Diluted Continuous Ops | 0.41 | 0.09 | 0.10 | 0.08 | 0.13 |
| EBITDA(a) | $11,734 | $10,248 | $10,777 | $8,097 | $13,913 |